Roger Léger

1.9k total citations · 1 hit paper
19 papers, 1.6k citations indexed

About

Roger Léger is a scholar working on Molecular Biology, Organic Chemistry and Molecular Medicine. According to data from OpenAlex, Roger Léger has authored 19 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Organic Chemistry and 6 papers in Molecular Medicine. Recurrent topics in Roger Léger's work include Antibiotic Resistance in Bacteria (6 papers), Chemical Synthesis and Analysis (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Roger Léger is often cited by papers focused on Antibiotic Resistance in Bacteria (6 papers), Chemical Synthesis and Analysis (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Roger Léger collaborates with scholars based in United States, Japan and Canada. Roger Léger's co-authors include Suzanne Chamberland, Ving J. Lee, Olga Lomovskaya, Scott J. Hecker, Kazuki Hoshino, Hiroko Ishida, W. J. Watkins, Johanne Blais, May Lee and Jorge L. Galazzo and has published in prestigious journals such as Journal of the American Chemical Society, Endocrinology and Journal of Medicinal Chemistry.

In The Last Decade

Roger Léger

19 papers receiving 1.5k citations

Hit Papers

Identification and Characterization of Inhibitors of Mult... 2001 2026 2009 2017 2001 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa : Novel Agents for Combination Therapy
    2001 731 citations Olga Lomovskaya, Mark S. Warren et al. Antimicrobial Agents and Chemotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Léger United States 16 981 735 443 253 246 19 1.6k
Hiroko Ishida Japan 16 1.1k 1.1× 783 1.1× 478 1.1× 142 0.6× 295 1.2× 28 1.8k
Ving J. Lee United States 21 1.4k 1.4× 1.0k 1.4× 687 1.6× 518 2.0× 365 1.5× 45 2.2k
Phaik‐Eng Sum United States 19 682 0.7× 534 0.7× 496 1.1× 290 1.1× 161 0.7× 32 1.5k
Dustin T. King Canada 19 952 1.0× 777 1.1× 454 1.0× 296 1.2× 277 1.1× 32 1.7k
Timothy J. Opperman United States 22 760 0.8× 991 1.3× 263 0.6× 178 0.7× 165 0.7× 36 1.7k
Katie J. Aldred United States 8 514 0.5× 738 1.0× 343 0.8× 240 0.9× 151 0.6× 11 1.3k
Carine Bebrone Belgium 22 1.3k 1.4× 641 0.9× 483 1.1× 224 0.9× 343 1.4× 30 1.9k
Darren Abbanat United States 19 821 0.8× 495 0.7× 565 1.3× 277 1.1× 294 1.2× 42 1.7k
Mei‐Ling Han Australia 26 673 0.7× 888 1.2× 309 0.7× 109 0.4× 170 0.7× 67 1.8k
Denis M. Daigle Canada 19 614 0.6× 695 0.9× 273 0.6× 112 0.4× 174 0.7× 28 1.3k

Countries citing papers authored by Roger Léger

Since Specialization
Citations

This map shows the geographic impact of Roger Léger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Léger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Léger more than expected).

Fields of papers citing papers by Roger Léger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Léger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Léger. The network helps show where Roger Léger may publish in the future.

Co-authorship network of co-authors of Roger Léger

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Léger. A scholar is included among the top collaborators of Roger Léger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Léger. Roger Léger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bose, Jeffrey L., Trudy H. Grossman, Alaina Kaiser, et al.. (2020). Controlling the Growth of the Skin Commensal Staphylococcus epidermidis Using d -Alanine Auxotrophy. mSphere. 5(3). 18 indexed citations
2.
3.
Thibaudeau, Karen, Roger Léger, Xicai Huang, et al.. (2005). Synthesis and Evaluation of Insulin−Human Serum Albumin Conjugates. Bioconjugate Chemistry. 16(4). 1000–1008. 38 indexed citations
4.
Léger, Roger, Karen Thibaudeau, Martin Robitaille, et al.. (2004). Identification of CJC-1131-albumin bioconjugate as a stable and bioactive GLP-1(7–36) analog. Bioorganic & Medicinal Chemistry Letters. 14(17). 4395–4398. 52 indexed citations
5.
Léger, Roger, et al.. (2004). Kringle 5 peptide–albumin conjugates with anti-migratory activity. Bioorganic & Medicinal Chemistry Letters. 14(4). 841–845. 15 indexed citations
6.
Nakayama, Kiyoshi, Yohei Ishida, Masami Ohtsuka, et al.. (2003). MexAB-OprM-Specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 1: Discovery and early strategies for lead optimization. Bioorganic & Medicinal Chemistry Letters. 13(23). 4201–4204. 66 indexed citations
7.
Watkins, William J., Roger Léger, Thomas E. Renau, et al.. (2003). The relationship between physicochemical properties, In vitro activity and pharmacokinetic profiles of analogues of diamine-Containing efflux pump inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(23). 4241–4244. 64 indexed citations
8.
Renau, Thomas E., Roger Léger, Eric M. Flamme, et al.. (2003). Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa. Bioorganic & Medicinal Chemistry Letters. 13(16). 2755–2758. 76 indexed citations
9.
Léger, Roger, Martin Robitaille, Omar Quraishi, et al.. (2003). Synthesis and in vitro analysis of atrial natriuretic peptide–albumin conjugates. Bioorganic & Medicinal Chemistry Letters. 13(20). 3571–3575. 16 indexed citations
10.
Renau, Thomas E., Roger Léger, Rose Yen, et al.. (2002). Peptidomimetics of Efflux Pump Inhibitors Potentiate the Activity of Levofloxacin in Pseudomonas aeruginosa. Bioorganic & Medicinal Chemistry Letters. 12(5). 763–766. 60 indexed citations
11.
Renau, Thomas E., Roger Léger, Eric M. Flamme, et al.. (2001). Addressing the stability of C-capped dipeptide efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa. Bioorganic & Medicinal Chemistry Letters. 11(5). 663–667. 50 indexed citations
12.
Lomovskaya, Olga, Mark S. Warren, Angela Lee, et al.. (2001). Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa : Novel Agents for Combination Therapy. Antimicrobial Agents and Chemotherapy. 45(1). 105–116. 731 indexed citations breakdown →
13.
Boojamra, Constantine G., Rémy C. Lemoine, Julie C. Lee, et al.. (2001). Stereochemical Elucidation and Total Synthesis of Dihydropacidamycin D, a Semisynthetic Pacidamycin. Journal of the American Chemical Society. 123(5). 870–874. 43 indexed citations
14.
Renau, Thomas E., Roger Léger, Eric M. Flamme, et al.. (1999). Inhibitors of Efflux Pumps in Pseudomonas aeruginosa Potentiate the Activity of the Fluoroquinolone Antibacterial Levofloxacin. Journal of Medicinal Chemistry. 42(24). 4928–4931. 219 indexed citations
15.
Oppolzer, Wolfgang, et al.. (1997). Studies Towards Asymmetric Catalyzed Metallo-ene Reactions. Tetrahedron Letters. 38(35). 6213–6216. 22 indexed citations
16.
Bélanger-Gariépy, F., Roger Léger, & S. Hanessian. (1992). Structure of a bicyclic organostannane resulting from a trimethyltin hydride addition-cyclization reaction. Acta Crystallographica Section C Crystal Structure Communications. 48(7). 1309–1310. 1 indexed citations
17.
Hanessian, Stephen & Roger Léger. (1992). Total Synthesis of the Lignan Antibiotic Burseran and a Novel Approach to the Podophyllotoxin Skeleton. Synlett. 1992(5). 402–404. 17 indexed citations
18.
Hanessian, Stephen, Roger Léger, & Marco Alpegiani. (1992). Free radical-induced C-allylation of α-bromolactones. Synthesis of 2-C-allyl-2-deoxy-d-arabino-and -d-ribono-1,4-lactones. Carbohydrate Research. 228(1). 145–155. 3 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroko Ishida Breakdown of academic impact, for papers by Ving J. Lee Breakdown of academic impact, for papers by Phaik‐Eng Sum Breakdown of academic impact, for papers by Dustin T. King Breakdown of academic impact, for papers by Timothy J. Opperman Breakdown of academic impact, for papers by Katie J. Aldred Breakdown of academic impact, for papers by Carine Bebrone Breakdown of academic impact, for papers by Darren Abbanat Breakdown of academic impact, for papers by Mei‐Ling Han Breakdown of academic impact, for papers by Denis M. Daigle
Rankless by CCL
2026